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ABSTRACT
Nisin and related lantibiotics kill bacteria by pore formation or by sequester-
ing Lipid II. Some lantibiotics sequester Lipid II into clusters, which were 
suggested to kill cells through delocalized peptidoglycan synthesis. Here, 
we show that cluster formation is always concomitant with (i) membrane 
pore formation and (ii) membrane depolarization. Nisin variants that cluster 
lipid II kill L-form bacteria with similar efficiency, suggesting that delocal-
ization of peptidoglycan synthesis is not the primary killing mechanism of 
these lantibiotics.
INTRODUCTION
Lantibiotics form a class of antimicrobial peptides that contain thioether 
rings formed by lanthionine residues. Nisin, the most studied lantibiotic, is 
a 34-residue peptide produced by Lactococcus species with antimicrobial ac-
tivity against a wide range of Gram-positive bacteria (Figure 1). Nisin targets 
Lipid II, the precursor molecule for peptidoglycan (PG) synthesis1, and kills 
via two modes of action: (i) formation of large membrane pores and (ii) in-
terference with PG synthesis.
Two lanthionine rings in nisin (A and B) form a pyrophosphate-binding 
cage that binds Lipid II and is highly conserved among Lipid II-binding lan-
tibiotics2. The C terminus of nisin is important for membrane integration3,4. 
Nisin-Lipid II complexes (8:4 stoichiometry) form pores in the membrane5–7 
that result in the efflux of small molecules and influx of sodium ions, which 
will lead to cell death. Mutations in the hinge region of nisin either block or se-
verely inhibit pore formation activity, presumably by preventing the hinge re-
gion (residues N20, M21, and K22) (Figure 1) from flipping the C-terminal tail 
into and across the membrane. Mutants PP-nisin (N20P M21P) and ΔΔ-nisin 
(ΔN20 ΔM21) fail to form pores in liposome efflux assays7,8. Nisin 1–22 (Δ23-34) 
cannot dissipate the membrane potential of sensitive Lactococcus species9in 
addition, (iv. Similar to nisin 1–22, mutacin 1140 and mersacidin bind Lipid 
II but are too short to span the membrane6,10. Mutants that do not efficiently 
form pores are thought to act by affecting cell wall synthesis only.
Two mechanisms for lantibiotic interference with PG synthesis are pro-
posed: “occlusion” and “clustering.” Occlusion is the binding to the pyrophos-
phate moiety of Lipid II, which blocks incorporation of Lipid II into glycan 
strands11. Clustering is the formation of nonphysiological domains containing 
Lipid II and nisin in the membrane, which results in delocalized PG synthesis12.
Figure 1. Wild-type nisin and hinge region mutants used in this study. PP-nisin is nisin 
(N20P, M21P); ΔΔ-nisin is nisin (ΔN20, ΔM21); nisin 1–22 is nisin (ΔT23-K34). Gray residues 
form thioether bridges (labeled A to E), other non-standard amino acid residues are shown 
dashed. Dha, 2,3-Didehydroalanine; Dhb, (Z)-2,3- didehydrobutyrine; Abu, D-aminobutyrine; 
Dal, D-alanine. Figure adapted from 1.
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Recently, we used PP-nisin as a tool to cluster Lipid II into domains to 
determine the effect of delocalized Lipid II on the localization of proteins in-
volved in PG synthesis13. PP-nisin was expected not to affect the membrane 
potential of live cells7; however, we found that PP-nisin induced membrane 
potential loss13. This compromised the localization of many membrane-as-
sociated proteins, including MreB14. Here, we further investigated the ef-
fects of various nisin mutants on Lipid II cluster formation and pore forma-
tion using live Bacillus subtilis cells.
RESULTS AND DISCUSSION 
The nisin, nisin variants, and other lantibiotics used in this study all dis-
played antibacterial activity against B. subtilis (Table 1), as determined using 
the resazurin microplate assay (REMA), which uses the resazurin-resorufin 
dye pair to assess the metabolic capacity of cells15. The MIC50s determined 
correspond well with MIC values reported in the literature for the various 
compounds8,16–18. The capacity of these compounds to cluster Lipid II was 
tested by microscopy. Lipid II was stained with a vancomycin- conjugated 
BODIPY (boron-dipyrromethene) fluorophore, and cells were imaged. 
Control cells show a large amount of Lipid II in the septum and additional 
Lipid II on the cell edges, whereas nisin and PP-nisin induce the formation 
of spotty clusters with the loss of defined fluorescent cell edges (Figure 2A 
and B), as reported previously12,13,19,20, although nisin was more potent at 
lower concentrations. ΔΔ-Nisin was less potent in cluster formation, with 
only 27% of cells showing clusters at 30 μg/ml and a minimum concentra-
tion at which cluster formation was observed of 20 μg/ml. This suggests 
that the presence of the two amino acids at positions 20 and 21 is important 
for clustering. Nisin 1–22 did not induce cluster formation even at a concen-
tration of 30 μg/ml, which is 3 times the measured MIC50 (Figure 2A and 
Table 1). Mersacidin and mutacin 1140 failed to cluster lipid II at concentra-
tions far above their MIC50 (Figure 2B and Table 1). This was surprising as 
all lantibiotics were expected to cluster Lipid II, as described for PP-nisin 
in giant unilamellar vesicles (GUVs) and live cells and for mutacin 1140 in 
GUVs only12. The hinge region mutants, nisin 1–22, and mutacin 1140 all 
have the ring A/B cage, yet mutacin 1140 and nisin 1–22 were not effective in 
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As not all lantibiotics tested clustered Lipid II, we decided to further study 
the pore-forming activity of nisin (variants) in live cells, using fluorescent 
dyes to monitor membrane depolarization and pore formation in 96-well 
plate assays. Membrane depolarization was measured in hyperpolarized 
cells with the membrane potential dye DiSC3(5). Addition of nisin leads to 
depolarization with a concomitant fluorescence increase with a 50% effec-
tive concentration (EC50) of 96 nM (Table 1; Figure 3). PP-nisin and ΔΔ-nisin 
were clearly not as active as nisin but caused complete membrane depolar-
ization at higher concentrations (Figure 3A), which was unexpected as they 
Figure 2. In vivo clustering of nisin and Lipid II is concentration dependent. (A) Fluorescence 
microscopy of B. subtilis 168 after incubation with nisin and staining of Lipid II with fluores-
cent vancomycin (Van-FL). Concentration-dependent clustering of Lipid II can be observed 
by a change in phenotype from cells with defined edges and without spots (asterisk) to cells 
that lost their edges and have a spotted appearance (arrow). The percentages of cells with 
clusters are indicated in parentheses for each group: wild-type nisin, n = 367 for high con-
centration and 285 for low; PP-nisin, n = 288 for high and 428 for low; ∆∆-nisin, n = 297 
for high and 303 for low; and nisin 1–22, n = 281 for high and 270 for low (Table 1). (B) 
Untreated cells stained with fluorescent vancomycin or treated with mersacidin or mutacin 
1140. Percentages of cells with clusters are shown in parentheses: for mersacidin, n = 248, 
and for mutacin 1140, n = 215. Scale bar, 2 μm (same for all panels). Fluorescence images 
were inverted for clarity.
were reported to be deficient in pore formation8,12. Nisin 1–22 was inactive in 
our depolarization assay, as reported earlier9.
The membrane depolarization observed with PP-nisin and ΔΔ-nisin 
was surprising; therefore, the pore formation capacity of these nisin vari-
ants was determined. The quenching of the membrane- permeable DNA 
stain SYTO9 by membrane-impermeable propidium iodide (PI) influx was 
used as a proxy for pore formation in live B. subtilis cells by nisin (variants). 
Efficient influx of the propidium probe was detected with nisin, with an EC50 
of 9.0 nM (Table 1; Figure 3B). PP-nisin also allows the passage of the probe 
in vivo only slightly less efficiently than nisin (Table 1; Figure 3B). ΔΔ-Nisin 
and nisin 1–22 are much less efficient in this assay (Figure 3B). ΔΔ-Nisin 
does not quite plateau, resulting in very wide confidence intervals for the 
EC50 (Table 1). SYTO9 quenching by nisin 1–22 reaches a plateau at half the 
level of quenching caused by nisin, indicating that nisin 1–22 can induce 
pore formation but not to the extent that membrane potential is altered. 
This assay does not resolve whether or not a subfraction of cells is responsi-
ble for the observed probe influx. It is possible that live cells can counteract 
the depolarization effects of pore formation to a certain extent — e.g., by re-
sealing unstable pores. The protonophore carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP) did not cause propidium influx (not shown), indicating 
that depolarization of the membrane alone does not cause propidium influx. 
A potassium efflux assay using the potassium indicator PBFI confirmed that 
nisin, PP-nisin, and ΔΔ-nisin cause potassium efflux, whereas nisin 1–22 
did not, but EC50s could not be determined for all nisin variants (Figure 4).
Figure 3. In vivo membrane depolarization and pore formation by nisin variants. (A) 
Membrane depolarization of rod-shaped B. subtilis by nisin (variants) was measured using 
the potentiometric dye DiSC3(5). (B) Pore formation by nisin was measured using the DNA 
binding dyes SYTO9 and propidium iodide. Upon pore formation, propidium enters the cell 
and quenches SYTO9 fluorescence. Curves in (A) and (B) were fitted with a dose-response 
relationship (solid lines) to obtain EC50 values (Table 1)
CHAPTER 2: In vivo cluster formation of nisin and Lipid II is correlated with membrane depolarizationCHAPTER 2: Results and discussion 80 81
All nisin variants that cluster Lipid II induced membrane depolariza-
tion. ΔΔ-Nisin induced both clustering and pore formation at much higher 
concentrations than nisin and PP-nisin, suggesting that both events are 
linked. To establish whether pore formation is the main killing mecha-
nism for these nisin variants, we used L-forms that grow and proliferate 
in the absence of a cell wall21. L-forms will be killed by nisin variants that 
form pores, while nisin variants that kill by inhibition of PG synthesis 
alone will be ineffective. Although Lipid II synthesis is blocked or reduced 
in L-forms, nisin is still effective against L-forms due to the presence of 
other precursor lipids similar to Lipid II (Lipids III and IV22). MIC values 
for nisin, PP-nisin, and ΔΔ-nisin in L-forms were either lower than or sim-
ilar to the MIC values for PG-containing cells (Table 1), indicating that all 
of these variants kill with a similar efficiency irrespective of the presence 
of a cell wall. The MIC50 for nisin 1–22 increased 5-fold. Membrane de-
polarization of L-forms was also found to be similar to depolarization of 
cells containing PG (Table 1; Figure 5). Thus, by using L-forms as a way to 
discern whether nisin variants kill exclusively by inhibiting PG synthesis 
or also by pore formation, we conclude that only nisin 1–22 — which kills 
Figure 4. In vivo potassium efflux of B. subtilis 168 by nisin variants. Concentration dependent 
decrease in fluorescence of PBFI-AM was normalized between 0 (no response) and 1 (max-
imal response) and the data was fitted using a dose-response curve (solid line). The experi-
ment confirmed the activity of nisin, PP-nisin and ΔΔ- nisin, and the absence of activity of 
nisin 1–22, that was measured by the membrane depolarization assay in Figure 3A. The weak 
response of the potassium dye required the use of large amounts of cells required for this 
assay (about 10-fold more than for the pore forming and membrane depolarization assays) —
thus the effects were only observed at higher concentrations of nisin variants. Therefore, the 
fits were not used to generate EC50 values.
cells much more efficiently when PG synthesis is required — predomi-
nantly targets PG synthesis.
The results presented here suggest that lantibiotic-induced cluster for-
mation of Lipid II coincides with membrane depolarization. Surprisingly, 
mutacin 1140 clusters Lipid II in GUVs 12 but fails to do so in live cells 
(Figure 2), and PP-nisin and ΔΔ-nisin formed pores in live cells, although 
they are inactive in pore formation in Lipid II-doped 1,2-dioleoyl-sn-glycero- 
3-phosphocholine (DOPC) liposomes8. This suggests that lantibiotics have 
a stronger pore-forming activity on live cell membranes, which could be 
caused by either differences in lipid composition, the presence of protein 
in the membranes, or the presence of a membrane potential. Neither Lipid 
II binding (by nisin 1–22 or mersacidin) nor membrane depolarization 
(e.g., by CCCP13) alone is sufficient to form Lipid II clusters. This strongly 
suggests that nisin-Lipid II cluster formation results in depolarization, al-
though we cannot formally exclude that depolarization results in clustering.
These findings have implications for the proposed killing modes of ni-
sin-like lantibiotics: nisin variants capable of membrane depolarization may 
inhibit PG synthesis as well, but our results suggest that this is not import-
ant for killing as cell-wall-less L-forms are killed by these compounds with 
similar or higher efficiency. Nisin 1–22, the only nisin variant that exclu-
sively targets PG synthesis, should work through occlusion not clustering, 
as we never observed clusters formed by Lipid II and nisin 1–22. Similarly, 
occlusion is the mode of action of mersacidin and mutacin. An implication 
Figure 5. In vivo membrane depolarization of L-forms by nisin variants. Dissipation of ΔΨ of 
B. subtilis LR2 ΔsacB was measured using DiSC3(5). Data were fitted using a dose-response 
curve (solid line)
 
FIG S4. In vivo membrane depola izat on of L-forms by nis  variants. Dissipation of 
ΔΨ of B. subtilis LR2 ΔsacB was measured using DiSC3(5). Data were fitted using a 
dose-response curve (solid line). 
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of our finding is that monitoring the effects of lantibiotic-mediated Lipid II 
delocalization on cell wall synthesis proteins is only possible for those pro-
teins that are not affected by the collapse of the membrane potential that is 
associated with Lipid II delocalization.
MATERIAL AND METHODS
Materials
Purified nisin, PP-nisin, ΔΔ-nisin, mersacidin and mutacin 1140 were 
gifts from Eefjan Breukink (University of Utrecht, the Netherlands), Oscar 
Kuipers (University of Groningen, the Netherlands) and Rick Rink (Lanthio 
Pharma, Groningen, the Netherlands). 3,3’-Dipropylthiadicarbocyanine io-
dide (DiSC3(5)), SYTO9, propidium iodide, Bodipy Fl-vancomycin (Van-FL) 
and potassium-binding benzofuran isophthalate acetoxy methyl ester 
(PBFI-AM) were obtained from Life Technologies. Resazurin was from BD 
Biosciences. Nutrient broth (NB) was from Oxoid. All other chemicals were 
from Sigma-Aldrich.
Strains 
The following bacterial strains were used in this study. Wild-type B. subtilis 
168 (trpC2) was obtained from lab stock and used for experiments on rod-
shaped cells, B. subtilis strain LR2 ΔsacB was used for experiments using 
L-forms. Strain LR2 ΔsacB was obtained after transformation of LR2 (trpC2 
ΩspoVD::cat Pxyl-murE ΩamyE::(tet xylR) xseB* (Frameshift 22T>-))23 to ka-
namycin resistance with chromosomal DNA from a strain were sacB was in-
activated by a mariner transposon containing a kanamycin cassette (B. sub-
tilis strain Bs168 sacB::TnKan). The phenotype of LR2 ΔsacB was checked 
by growing on sucrose containing plates, confirming that LR2 ΔsacB has 
lost the capability to create water-like droplets of levan. Strains LR2 and 
Bs168 sacB::TnKan were kind gifts of Patricia Dominguez Cuevas and Jeff 
Errington (University of Newcastle, United Kingdom).
Culture conditions
Unless stated otherwise B. subtilis rods were grown in lysogeny broth (LB) at 
37 °C. Bacterial L-forms of strain LR2 (and derivatives) were created accord-
ing to24. Rod-shaped cells capable of forming L-forms were collected from 
an overnight culture by centrifugation and resuspended into MSM-NB, a 1:1 
(v/v) mix of 2 × MSM (40 mM MgCl2, 1 M sucrose, and 40 mM maleic acid, 
pH 7) and 2 × nutrient broth (NB). Protoplasts were generated by addition of 
lysozyme (0.5 mg/ml) followed by a 30 min incubation at 30 °C. Protoplasts 
were spun down at 3000 × g for 10 min, resuspended in MSM-NB and di-
luted 1:1000 into MSM-NB containing 200 µg/ml Penicillin G. Proliferating 
L-forms were diluted twice per week 1:1000 into fresh MSM-NB containing 
PenG. L-form cultures used for assays were between 3 and 7 weeks old to 
ensure that a stable culture had been formed, and L-form formation was 
confirmed before use by visual inspection using a microscope.
Microscopy
B. subtilis 168 were diluted 1:100 from an overnight culture in LB into casein 
hydrolysate (CH) medium (25 and references therein) and incubated at 30 °C 
until growing exponentially. Cells were collected for microscopy by centrif-
ugation and resuspended in 1/10th of a volume in PBS. Nisin variants were 
added to this bacterial suspension at various concentrations and incubated 
for 5 min. Subsequently, Lipid II was stained with a 1:1 mixture of vancomy-
cin and Van-FL at a final concentration of 1 µg/ml19. A 3 µl sample of this 
suspension was immobilized on an agarose pad (1% in PBS) and mounted 
on a Nikon Ti-E inverted microscope equipped with a CFI Plan Apochromat 
DM 100× oil objective. Digital images were recorded using a Hamamatsu 
Orca Flash 4.0 camera, analyzed using ImageJ26 and prepared using Adobe 
Photoshop.
Resazurin microtiter assay
Cell viability was measured using the resazurin microtiter assay (REMA) as 
described15. For rod-shaped bacteria, nisin variants were serially diluted two-
fold in 100 µl LB in a flat-bottomed 96-well plate. 100 µl LB containing a 1:10 
dilution of bacteria from an overnight culture were added per well (final 
OD600 of 0.15-0.20). For L-forms, nisin variants were serially diluted two-fold 
in 50 µl deionized water in a 96- well plate. 125 µl 1.4× MSM-NB was added 
to each well, followed by 10 µl of an L-forms culture (final OD600 of 0.15-0.20). 
Subsequently, plates containing rod-shaped bacteria or L-forms were incu-
bated for up to 4 hours. Cell viability was measured by adding 15 µl 0.01% 
(w/v) resazurin, followed by an incubation of 30 min at 37 °C in the dark. 
Viable microorganisms reduce the blue dye resazurin to pink resorufin, 
which was quantified with a Synergy MX (Biotek) fluorescence plate reader 
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using 530 nm excitation and 590 nm emission wavelengths. The MIC-value 
was determined as the last concentration of the dilution series still capable 
of inhibiting 50% of resazurin reduction. 
Membrane potential assay
In vivo measurements of membrane potential dissipation by nisin variants 
using the membrane potential sensitive dye DiSC3(5) was adapted from
9. 
A  two-fold dilution series of nisin (variants) was made in a flat-bottomed 
96-well plate. Then DiSC3(5) and valinomycin were added from a stock solu-
tions of EtOH to final concentrations 6 µM and 0.2 µM, respectively. Then 
medium was added, for rodshaped bacteria PIPES/NaOH pH 7 (final con-
centration 50 mM) was used, for L-forms MSM (1× final concentration). Last, 
bacteria (rods or L-forms) were added from an overnight culture to a final 
OD600 of 0.15–0.20. The contents of the wells were briefly mixed and fluo-
rescence was measured with a Synergy MX fluorescence plate reader us-
ing 630 nm emission and 670 nm excitation wavelengths. The potassium 
ionophore valinomycin was added to generate a ΔΨ, leading to a decrease 
in fluorescence of DiSC3(5) as ΔΨ-dependent DiSC3(5) accumulation in the 
membrane results in quenching. Dissipation of the ΔΨ by nisin results in a 
redistribution of DiSC3(5) in the membrane with a concomitant increase of 
fluorescence9. Fluorescence data was background corrected and fitted with a 
doseresponse relationship (EC50 = max × concn / (EC50n + concn)) in Matlab 
using a nonlinear least-squares algorithm. 
Pore formation assay
In vivo pore formation of nisin variants was measured using the DNA bind-
ing dyes SYTO9 and propidium iodide (adapted from the Live/Dead bac-
terial viability assay (Life Technologies)). A two-fold dilution series of ni-
sin variants was made in a flat-bottomed 96-well. Depending on whether 
rod-shaped or L-form bacteria were used the medium consisted of 50 mM 
PIPES/NaOH pH 7 or 1× MSM, respectively (final concentrations). SYTO9 
and propidium iodide were added to final concentrations of 4.2 and 25 µM, 
respectively. Bacteria (rods or L-forms) were added from an overnight cul-
ture to a final OD600 of 0.15–0.20. The contents of the wells were briefly 
mixed and fluorescence was measured with a Synergy MX fluorescence 
plate reader using 485 nm emission and 530 nm excitation wavelengths. 
Upon membrane permeabilization by variants of nisin, propidium enters 
the cell and effectively quenches SYTO9 fluorescence. Quenching values of 
SYTO9 were background corrected, normalized to wild-type nisin levels and 
fitted with a dose-response curve as described above. 
Potassium efflux assay
Nisin-induced efflux of potassium was measured using PBFI-AM as de-
scribed in27. Briefly, bacteria were grown until OD600 of 1.6 and washed 
5 times in buffer (5 mM HEPES pH 7.5, 5 mM glucose). The bacterial sus-
pension was added to a 96-well plate containing a 1:2 dilution series of ni-
sin variants and 2 µM of PBFI-AM and briefly vortexed to mix the contents. 
After 1 hour, fluorescence was measured using a Synergy MX plate reader 
with an excitation wavelength of 346 nm and emission wavelength of 508 
nm. Fluorescence values were corrected for background and normalized be-
tween 0 (no response) and 1 (maximal response) and fitted with a dose-re-
sponse curve as described above.
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